Freedom Partners Leaves FDA Rules Off CRA Short List; Targets EHR, Exchange Rules
January 17, 2017
FDA rules didn't make the short-list of regulations targeted by a conservative think tank in ongoing meetings with congressional Republicans for repeal under the Congressional Review Act, but Freedom Partners is separately pushing an FDA reform agenda that includes state passage of right-to-try legislation and expediting U.S. approval of drugs cleared by other countries, sources with the group tell Inside Health Policy . Although the group's short list doesn't specify any FDA regulations, it targets two HHS rules: the Electronic...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to their next steps following the collapse of their efforts to repeal and replace.